Papaverine Hydrochloride
PAPAVERINE HYDROCHLORIDE INJECTION, USP
Approved
Approval ID
1e76839f-82eb-42a8-abc2-e7fbc533082d
Product Type
HUMAN PRESCRIPTION DRUG LABEL
Effective Date
Jan 31, 2023
Manufacturers
FDA
Nexus Pharamaceuticals Inc.
DUNS: 620714787
Products 1
Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.
Papaverine Hydrochloride
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
NDC Product Code14789-121
Product Classification
G
Generic Name
Papaverine Hydrochloride
Product Specifications
Route of AdministrationINTRAVENOUS, INTRAMUSCULAR
Effective DateMay 1, 2023
FDA Product Classification
INGREDIENTS (4)
Papaverine HydrochlorideActive
Quantity: 30 mg in 1 mL
Code: 23473EC6BQ
Classification: ACTIB
Sodium CitrateInactive
Code: 1Q73Q2JULR
Classification: IACT
Edetate DisodiumInactive
Quantity: 0.05 mg in 1 mL
Code: 7FLD91C86K
Classification: IACT
Citric Acid MonohydrateInactive
Code: 2968PHW8QP
Classification: IACT